Hemagen Diagnostics Inc HMGN:OTCPK

RT Quote | Exchange | USD
Last | 10:07 AM EST
0.049quote price arrow down-0.001 (-2.00%)
Volume
5,600
52 week range
0.01 - 0.05

...

Loading . . .

KEY STATS

  • Open0.0375
  • Day High0.049
  • Day Low0.0375
  • Prev Close0.05
  • 52 Week High0.05
  • 52 Week High Date03/01/21
  • 52 Week Low0.01
  • 52 Week Low Date12/30/20
  • Market Cap760,000.00
  • Shares Out15.50M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.16
  • 1 Year % Change636.84

RATIOS/PROFITABILITY

  • EPS (TTM)-0.06
  • P/E (TTM)-0.84
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-273,670.00
  • ROE (MRQ)-
  • Revenue (MRQ)4.04M
  • Gross Margin (MRQ)39.92%
  • Net Margin (MRQ)-22.45%
  • Debt To Equity (MRQ)-141.33%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Hemagen Diagnostics Inc News

There is no recent news for this security.

Latest HMGN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Hemagen Diagnostics, Inc. is engaged in providing clinical diagnostic solutions. The Company is primarily focused on Veterinary Clinical Diagnostics. It is also focused on VIRGO, its Human Clinical Diagnostic line of autoimmune and infectious disease products. Its assays utilize multiple technologies, including Enzyme Linked Immunosorbent Assay (ELISA), immunofluorescence (IFA) and hemagglutination (HA). Its product, HEMASORB NSD, is designed to remove interfering substances...
William Hales
Chairman
M. Robert Campbell
Chief Financial Officer
Catherine Davidson
Chief Accounting Officer
Address
9033 Red Branch Rd
Columbia, MD
21045-2396
United States